We are solely focused on pioneering precision-based kidney medicines.
Welcome to Goldfinch Bio
With our sole focus on kidney diseases, we aspire to be the world’s leading precision medicine kidney company. Patients often have limited therapeutic options that target the underlying cause of disease. Our solution to address this growing need is applying precision medicine to pioneer the discovery, development and commercialization of kidney disease treatments. The goal of precision medicine is not only to advance more effective and targeted medicines, but also to reduce the potential for harm and reduce healthcare costs arising from unnecessary treatments.
A ‘One Size Fits All’ Approach Has Failed People Living with Kidney Disease
Historically, there has been a ‘one size fits all’ approach to treating kidney disease. This has been due to the lack of understanding of kidney disease at the molecular level. Current treatments, including off-label therapies, address the symptoms of kidney disease but result in severe side effects; they are not designed to treat the root cause of disease. Many people living with kidney disease follow the same trajectory, ultimately progressing from onset to end-stage kidney disease where they ultimately endure a challenging treatment regimen that involves a combination of dialysis and transplantation, significantly impacting their and their family’s quality of life. There are no treatments that can protect those affected by kidney disease – and their kidneys – from following this path.